2024
MP24-20 IMPACT OF MENTAL HEALTH ILLNESS ON ADHERENCE TO SURVEILLANCE AND TREATMENT GUIDELINES IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS
Grajales V, Duan Z, Tan W, Contieri R, Myers A, Zhao H, Giordano S, Williams S, Kamat A. MP24-20 IMPACT OF MENTAL HEALTH ILLNESS ON ADHERENCE TO SURVEILLANCE AND TREATMENT GUIDELINES IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS. Journal Of Urology 2024, 211: e401. DOI: 10.1097/01.ju.0001008860.46052.c4.20.Peer-Reviewed Original Research
2023
International Bladder Cancer Group Intermediate-risk Nonmuscle-invasive Bladder Cancer Scoring System Predicts Outcomes of Patients on Active Surveillance
Tan W, Contieri R, Buffi N, Lughezzani G, Grajales V, Soloway M, Casale P, Hurle R, Kamat A. International Bladder Cancer Group Intermediate-risk Nonmuscle-invasive Bladder Cancer Scoring System Predicts Outcomes of Patients on Active Surveillance. Journal Of Urology 2023, 210: 763-770. PMID: 37535836, DOI: 10.1097/ju.0000000000003639.Peer-Reviewed Original ResearchTransurethral resection of bladder tumorResection of bladder tumorNonmuscle-invasive bladder cancerTransurethral resectionBladder tumorsActive surveillanceBladder cancerScoring systemNonmuscle-invasive bladder cancer patientsAbsence of gross hematuriaMultivariate Cox proportional hazards analysisRisk factorsNonmuscle-invasive bladder tumorsNegative urinary cytologyCox proportional hazards analysisMedian follow-upMultivariate Cox regressionBladder cancer patientsProportional hazards analysisUrinary cytologyGross hematuriaT stageLandmark time pointsFollow-upCox regressionMP63-06 BACILLUS CALMETTE-GUERIN VS IMMEDIATE RADICAL CYSTECTOMY IN EAU DEFINED VERY HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS
Contieri R, Hensley P, Tan W, Grajales V, Bree K, Guo C, Nogueras-Gonzalez G, Navai N, Dinney C, Kamat A. MP63-06 BACILLUS CALMETTE-GUERIN VS IMMEDIATE RADICAL CYSTECTOMY IN EAU DEFINED VERY HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS. Journal Of Urology 2023, 209: e873. DOI: 10.1097/ju.0000000000003321.06.Peer-Reviewed Original ResearchNon-muscle invasive bladder cancer patientsInvasive bladder cancer patientsBladder cancer patientsCancer patientsMP63-11 ADVANCED AGE (>70 YEARS) DOES NOT AFFECT ONCOLOGICAL OUTCOMES IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS TREATED WITH ADEQUATE BACILLUS CALMETTE-GUERIN: A COMPETING RISK ANALYSIS FROM a TERTIARY CARE CENTER.
Contieri R, Grajales V, Tan W, Bree K, Hensley P, Guo C, Nogueras-Gonzalez G, Navai N, Dinney C, Kamat A. MP63-11 ADVANCED AGE (>70 YEARS) DOES NOT AFFECT ONCOLOGICAL OUTCOMES IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS TREATED WITH ADEQUATE BACILLUS CALMETTE-GUERIN: A COMPETING RISK ANALYSIS FROM a TERTIARY CARE CENTER. Journal Of Urology 2023, 209: e875. DOI: 10.1097/ju.0000000000003321.11.Peer-Reviewed Original ResearchA0722 Bacillus calmette-guerin vs immediate radical cystectomy in eau defined very high-risk non-muscle invasive bladder cancer patients
Contieri R, Hensley P, Grajales V, Tan W, Bree K, Guo C, Nogueras-Gonzalez G, Navai N, Dinney C, Kamat A. A0722 Bacillus calmette-guerin vs immediate radical cystectomy in eau defined very high-risk non-muscle invasive bladder cancer patients. European Urology 2023, 83: s1023-s1024. DOI: 10.1016/s0302-2838(23)00766-2.Peer-Reviewed Original Research
2020
776 Intravesical chemohyperthermia (HIVEC-E) in BCG unresponsive non-muscle invasive bladder cancer patients: Oncological outcomes of a multi-centre European registry
Tan W, Chiancone F, Fedelini P, Boormans J, De Jong J, Wilby D, Robinson R, Poggio M, Escudero J, Goizueta F, Plata A, Vögeli T, Escandón A, Nzeh C, De La Morena J, Moreno J, Guerrero F, Torres J, Hendricksen K. 776 Intravesical chemohyperthermia (HIVEC-E) in BCG unresponsive non-muscle invasive bladder cancer patients: Oncological outcomes of a multi-centre European registry. European Urology Open Science 2020, 19: e1181-e1182. DOI: 10.1016/s2666-1683(20)33376-0.Peer-Reviewed Original ResearchInequity in selective referral to high-volume hospitals for genitourinary malignancies
Berg S, Tully K, Sahraoui A, Tan W, Krimphove M, Marchese M, Lipsitz S, Noldus J, Trinh Q. Inequity in selective referral to high-volume hospitals for genitourinary malignancies. Urologic Oncology Seminars And Original Investigations 2020, 38: 582-589. PMID: 32217041, DOI: 10.1016/j.urolonc.2020.02.013.Peer-Reviewed Original ResearchConceptsHigh-volume hospitalsBladder cancerPredictors of treatmentCancer patientsRadical prostatectomyProstate cancerMuscle-invasive urothelial bladder cancerNegative predictors of treatmentBlack raceNational Cancer DatabaseNonmetastatic prostate cancerUrothelial bladder cancerProstate cancer patientsBladder cancer patientsMultivariate logistic regression modelAssociated with lower ratesKidney cancer patientsPrivate insurance statusAssociated with lower oddsAssociated with greater oddsLow-volume hospitalsRadical cystectomyReceipt of treatmentGenitourinary malignanciesPerioperative morbidity
2019
PD13-10 ONCOLOGICAL OUTCOMES OF BCG UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS TREATED WITH POSTOPERATIVE CHEMOHYPERTHERMIA: A MULTICENTRE EUROPEAN RETROSPECTIVE ANALYSIS.
Tan* W, Hendricksen K, Wilby D, Nzeh C, Goizueta J, Vilmar W, Bello A, Sousa A, Morena J, Pontones J, Guerrero F, Kalchev I, Frank E, Boormans J. PD13-10 ONCOLOGICAL OUTCOMES OF BCG UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS TREATED WITH POSTOPERATIVE CHEMOHYPERTHERMIA: A MULTICENTRE EUROPEAN RETROSPECTIVE ANALYSIS. Journal Of Urology 2019, 201 DOI: 10.1097/01.ju.0000555390.06113.0b.Peer-Reviewed Original ResearchMP32-10 COMPARATIVE EFFECTIVENESS OF ROBOTIC ASSISTED AND OPEN RADICAL CYSTECTOMY IN CONTEMPORARY COHORTS OF BLADDER CANCER PATIENTS: AN INTERNATIONAL MULTICENTER COLLABORATION
Zamboni* S, Soria F, Mathieu R, Xylinas E, D'Andrea D, Abufaraj M, Tan W, Kelly J, Simone G, Gallucci M, Meraney A, Krishna S, Konety B, Montorsi F, Briganti A, Mattei A, Baumeister P, Antonelli A, Simeone C, Rink M, Aziz A, Karakiewicz P, Rouprêt M, Perry M, Rowe E, Koupparis A, Scherr D, Ploussard G, Sooriakumaran P, Shariat S, Moschini M. MP32-10 COMPARATIVE EFFECTIVENESS OF ROBOTIC ASSISTED AND OPEN RADICAL CYSTECTOMY IN CONTEMPORARY COHORTS OF BLADDER CANCER PATIENTS: AN INTERNATIONAL MULTICENTER COLLABORATION. Journal Of Urology 2019, 201 DOI: 10.1097/01.ju.0000555883.61031.df.Peer-Reviewed Original Research843 Comparative effectiveness of robotic assisted and open radical cystectomy in contemporary cohorts of bladder cancer patients: An international multicenter collaboration
Zamboni S, Soria F, Mathieu R, Xylinas E, Tan W, Kelly J, Simone G, Gallucci M, Meraney A, Konety B, Antonelli A, Simeone C, Baumeister P, Mattei A, Montorsi F, Briganti A, Rink M, Aziz A, Karakiewicz P, Rouprêt M, Scherr D, Ploussard G, Sooriakumaran P, Shariat S, Moschini M, Urologists U. 843 Comparative effectiveness of robotic assisted and open radical cystectomy in contemporary cohorts of bladder cancer patients: An international multicenter collaboration. European Urology Open Science 2019, 18: e1139-e1140. DOI: 10.1016/s1569-9056(19)30821-8.Peer-Reviewed Original Research
2018
Novel urinary biomarkers for the detection of bladder cancer: A systematic review
Tan W, Tan W, Tan M, Khetrapal P, Dong L, deWinter P, Feber A, Kelly J. Novel urinary biomarkers for the detection of bladder cancer: A systematic review. Cancer Treatment Reviews 2018, 69: 39-52. PMID: 29902678, DOI: 10.1016/j.ctrv.2018.05.012.Peer-Reviewed Original ResearchConceptsNegative predictive valuePositive predictive valueUrinary biomarkersBladder cancerReceiver operating characteristicRisk of biasPredictive valueNon-muscle invasive bladder cancer patientsBiomarkers investigated to dateInvasive bladder cancer patientsDetection of bladder cancerDiagnosis of bladder cancerSystematic reviewNovel urinary biomarkersBladder cancer patientsQUADAS-2 toolCase-control studyAssessed risk of biasSpecificity of biomarkersPositive test resultsSystematic searchUrinary cytologySurveillance cystoscopyComprehensive systematic reviewQUADAS-2